Last Price
1.03
Today's Change
+0.279 (37.15%)
Day's Change
0.883 - 1.60
Trading Volume
108,333,387
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Dane Carl Andreeff Mr. Dane Carl Andreeff
Full Time Employees: 22 22
IPO Date: 2014-06-27 2014-06-27
CIK: 0001610853 0001610853
ISIN: US42328V8019 US42328V8019
CUSIP: 42328V504 42328V504
Beta: 1.61 1.61
Last Dividend: 0.00 0.00
Dcf Diff: -0.16 -0.16
Dcf: 1.07 1.07
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.